Baxter Launches Olimel N12 In Europe to Meet High Protein Needs in Critically Ill Patients
CRACOW, Poland–(BUSINESS WIRE)– Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, announced today the European launch of Olimel N12, the new addition...